Stocktoria
Quantum-Si Inc QSI
Quantum-Si Inc (QSI) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $2.4M at a -4160.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.87 — grey zone (between the usual thresholds). A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.622 |
| Retained earnings / assets | -2.842 |
| EBIT / assets | -0.473 |
| Equity / liabilities | 8.677 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| QSI | Quantum-Si Inc | 1/9 | 0.75 | — | — |
| UCLE | US NUCLEAR CORP. | 5/9 | — | — | — |
| AATC | AUTOSCOPE TECHNOLOGIES CORP | 5/9 | 11.38 | 12.8 | +0.5% |
| BCHT | Birchtech Corp. | 4/9 | — | — | +1.3% |
| MASS | 908 Devices Inc. | 3/9 | 1.84 | 17 | +17.7% |
| OWLT | Owlet, Inc. | 4/9 | -9.08 | — | +35.4% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | 1/9 | 8.01 | — | -18.3% |
About Quantum-Si Inc
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
FAQ
Is QSI financially healthy?
Quantum-Si Inc's Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does QSI pay a dividend?
No, Quantum-Si Inc does not currently pay a dividend.
How profitable is QSI?
In FY2025, Quantum-Si Inc had a net margin of -4160.1% and a return on equity of -46.0%.
What is the analyst price target for QSI?
The average Wall-Street price target for Quantum-Si Inc is $2.50, about 198.5% above the recent price, from 3 analysts.
Is QSI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Quantum-Si Inc: a Piotroski F-score of 1/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.